Clinical trial
Feasibility of the Multiple Sclerosis Performance Test for Assessment of Functional Performance Measures in Patients With Multiple Sclerosis
NCT03926637 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of the Multiple Sclerosis Performance Test for Assessment of Functional Performance Measures in Patients With Multiple Sclerosis
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 17, 2019
- Completion date
- December 5, 2022
- Enrollment
- 3,073 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.